Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
TANG CAPITAL MANAGEMENT LLC (CIK 1232621) reported $2.20B across 41 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: AUPH ($221.4M, 10.05%), SYRE ($168.0M, 7.63%), MIRM ($144.7M, 6.57%), KNSA ($144.5M, 6.56%), CELC ($137.5M, 6.25%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AUPH | AURINIA PHARMACEUTICALS INC | $221.4M | 10.05% | 13.0M | Added |
| 2 | SYRE | SPYRE THERAPEUTICS INC | $168.0M | 7.63% | 1.9M | Hold |
| 3 | MIRM | MIRUM PHARMACEUTICALS INC | $144.7M | 6.57% | 1.2M | Hold |
| 4 | KNSA | KINIKSA PHARMACEUTICALS INTL | $144.5M | 6.56% | 2.3M | Hold |
| 5 | CELC | CELCUITY INC | $137.5M | 6.25% | 1.3M | Added |
| 6 | CORT | CORCEPT THERAPEUTICS INC | $130.4M | 5.92% | 1.5M | Hold |
| 7 | PTCT | PTC THERAPEUTICS INC | $122.4M | 5.56% | 1.5M | Hold |
| 8 | LKFT | LAKEFRONT BIOTHERAPEUTICS NV | $113.5M | 5.16% | 3.8M | Hold |
| 9 | TARS | TARSUS PHARMACEUTICALS INC | $98.7M | 4.48% | 1.6M | Added |
| 10 | CAPR | CAPRICOR THERAPEUTICS INC | $98.7M | 4.48% | 4.1M | Added |
| 11 | SPY | STATE STR SPDR S&P 500 ETF T | $91.9M | 4.17% | 123,000 | Trimmed |
| 12 | ANAB | ANAPTYSBIO INC | $89.8M | 4.08% | 1.3M | Hold |
| 13 | IMCR | IMMUNOCORE HLDGS PLC | $84.1M | 3.82% | 2.6M | Hold |
| 14 | CMPS | COMPASS PATHWAYS PLC | $70.8M | 3.21% | 5.0M | Added |
| 15 | ANIP | ANI PHARMACEUTICALS INC | $58.6M | 2.66% | 707,500 | Hold |
| 16 | BNTX | BIONTECH SE | $43.7M | 1.99% | 470,000 | Hold |
| 17 | CMPX | COMPASS THERAPEUTICS INC | $39.4M | 1.79% | 18.0M | Added |
| 18 | PGEN | PRECIGEN INC | $36.6M | 1.66% | 6.4M | Hold |
| 19 | VRDN | VIRIDIAN THERAPEUTICS INC | $32.9M | 1.50% | 1.8M | Hold |
| 20 | NVCT | NUVECTIS PHARMA INC | $28.5M | 1.29% | 1.6M | New |
| 21 | DNTH | DIANTHUS THERAPEUTICS INC | $25.8M | 1.17% | 264,692 | Hold |
| 22 | FULC | FULCRUM THERAPEUTICS INC | $23.9M | 1.08% | 6.5M | New |
| 23 | AVIR | ATEA PHARMACEUTICALS INC | $22.4M | 1.02% | 4.8M | Hold |
| 24 | CBIO | CRESCENT BIOPHARMA INC. | $20.9M | 0.95% | 1.2M | Hold |
| 25 | NNDM | NANO DIMENSION LTD | $20.7M | 0.94% | 14.3M | New |
Source: SEC Form 13F filings · as of 2026-06-30